Most eukaryotic cells have a primary cilium which functions as a sensory organelle 1 . Cilia are assembled by intraflagellar transport (IFT), a process mediated by multimeric IFT particles and molecular motors 2 . Here we show that lymphoid and myeloid cells, which lack primary cilia, express IFT proteins. IFT20, an IFT component essential for ciliary assembly 3,4 , was found to colocalize with both the microtubule organizing centre (MTOC) and Golgi and post-Golgi compartments in T-lymphocytes. In antigen-specific conjugates, IFT20 translocated to the immune synapse. IFT20 knockdown resulted in impaired T-cell receptor/CD3 (TCR/CD3) clustering and signalling at the immune synapse, due to defective polarized recycling. Moreover, IFT20 was required for the inducible assembly of a complex with other IFT components (IFT57 and IFT88) and the TCR. The results identify IFT20 as a new regulator of immune synapse assembly in T cells and provide the first evidence to implicate IFT in membrane trafficking in cells lacking primary cilia, thereby introducing a new perspective on IFT function beyond its role in ciliogenesis.
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Most eukaryotic cells have a primary cilium which functions as a sensory organelle 1 . Cilia are assembled by intraflagellar transport (IFT), a process mediated by multimeric IFT particles and molecular motors 2 . Here we show that lymphoid and myeloid cells, which lack primary cilia, express IFT proteins. IFT20, an IFT component essential for ciliary assembly 3, 4 , was found to colocalize with both the microtubule organizing centre (MTOC) and Golgi and post-Golgi compartments in T-lymphocytes. In antigen-specific conjugates, IFT20 translocated to the immune synapse. IFT20 knockdown resulted in impaired T-cell receptor/CD3 (TCR/CD3) clustering and signalling at the immune synapse, due to defective polarized recycling. Moreover, IFT20 was required for the inducible assembly of a complex with other IFT components (IFT57 and IFT88) and the TCR. The results identify IFT20 as a new regulator of immune synapse assembly in T cells and provide the first evidence to implicate IFT in membrane trafficking in cells lacking primary cilia, thereby introducing a new perspective on IFT function beyond its role in ciliogenesis.
When naive T cells encounter antigen-presenting cells (APCs) bearing cognate major histocompatibility complex (MHC)-bound peptide antigen, a dynamic rearrangement of membrane and cytosolic molecules occurs at the T-cell-APC contact area. This results in the formation of a highly organized interface known as the immune synapse, which functions as a platform for signal integration, fine-tuning and extinction 5, 6 . A hallmark of the nascent immune synapse is reorientation of the MTOC towards the APC 7 , which ensures targeted delivery of signalling molecules from intracellular pools to the immune synapse 8 . This includes delivery of the TCR/CD3 complex, which is carried to the immune synapse through polarized recycling 9 . Directional movement of structural and regulatory molecules, orchestrated by the MTOC, is a characteristic feature of primary cilia. These projections, present on most non-dividing cells, function as sensory organelles, relaying information from the external environment into the cell through IFT, a process carried out by multimeric IFT particles and molecular motors 2, 10 .
Unlike most other eukaryotic cell types, hematopoietic cells lack primary cilia 10 . Surprisingly, IFT20, an IFT component essential for ciliary assembly 3, 4 , was found to be expressed in human cells of both lymphoid (peripheral blood lymphocytes and Jurkat T-lymphoma cells) and myeloid (monocytes and monocyte-derived dendritic cells) lineages (Fig. 1a) . Similar results were obtained in mouse, where IFT20 was detectable in central (thymus and bone marrow) and peripheral (lymph node and spleen) lymphoid organs (Fig. 1a) . Immunofluorescence analysis of Jurkat cells and human peripheral blood lymphocytes showed that IFT20 was localized to a discrete cytosolic region centered around the MTOC ( for human peripheral blood lymphocytes), which duplicated at early prophase (data not shown). No IFT20 staining was detectable during metaphase and anaphase, with the exception of two small punctate structures corresponding to the MTOCs (Fig. 1b-d) , as confirmed by co-staining with anti-γ-tubulin antibodies (Fig. 1c, d) , and by the IFT20 staining pattern in cells extracted with Triton X-100 to solubilize cell membranes ( Supplementary Information, Fig. S1b ). At late telophase and cytokinesis, IFT20 reassembled in the larger structure surrounding the MTOC (Fig. 1b) . Excluding the staining corresponding to the MTOC(s) (~40% colocalization), the pattern of IFT20 localization was indicative of the Golgi, which undergoes fragmentation during mitosis. Co-staining of Jurkat cells with antibodies specific to Golgi markers or other membrane compartments showed that IFT20 colocalizes to a significant extent (~60%) with the cis-Golgi (identified by GM130; Fig. 1c, d ). Treatment of Jurkat cells with brefeldin-A, which induces Golgi fragmentation, resulted in a largely similar dissipation of Golgiand IFT20-specific immunostaining ( Supplementary Information,  Fig. S1c ), further supporting the Golgi association of IFT20. It was found that IFT20 also colocalized, albeit to a more limited extent, with the trans-Golgi network (identified by TGN46; ~23%), recycling endosomes (identified by TfR; ~19%) and early endosomes (identified by EEA1; ~16%), whereas minimal colocalization with lysosomes (identified by LAMP-1; < 10%) was detected (Fig. 1c, d ). Hence, IFT20 is expressed in T-lymphocytes where it colocalizes with both the Golgi and MTOC, as it does in ciliated cells 10 , notwithstanding the absence of a primary cilium. Moreover, IFT20 associates, albeit to a lesser extent, with other membrane compartments implicated in protein trafficking.
Among the most dramatic events in immune synapse formation is the translocation of the MTOC and Golgi to the contact area between T cells and APCs
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. As IFT20 associates with both organelles, we analysed the localization of IFT20 in conjugates of Jurkat T cells and Raji B cells (used as APCs) loaded with staphyloccal enterotoxin E (SEE). IFT20 was found to translocate to the immune synapse, together with the MTOC and Golgi, in T cells ( Fig. 2a, b; Supplementary Information, Fig. S2a ). As expected, the TCR/CD3 complex clustered at the immune synapse, concomitant with MTOC and Golgi reorientation (Fig. 2a, b) . Similar effects occurred after capping the TCR/CD3 complex using anti-CD3 mAb and secondary antibodies ( Supplementary Information, Fig. S2b ), a procedure which results in TCR/CD3 clustering and MTOC and Golgi reorientation under the TCR cap 11 . IFT20 translocation to the immune synapse in antigen-specific conjugates was also observed in T-cells purified from healthy donors (Fig. 2f) . Interestingly, IFT20 not only clustered at the immune synapse together with the TCR, but also inducibly associated with the receptor complex subunits CD3ζ and CD3ε in response to TCR engagement (Fig. 2c) . No association with the linker for activation of T-cells (LAT), which also localizes at the immune synapse, was detected (data not shown), underscoring the specificity of the IFT20-CD3 interaction.
To assess the potential role of IFT20 in immune synapse formation, IFT20 expression was stably knocked down in Jurkat cells by RNA interference (RNAi; Fig. 2d ). A transfectant generated with an empty vector was used as a control. Both the MTOC and Golgi translocated to the immune synapse in IFT20-knockdown cells stimulated with SEE-loaded APCs, similarly to control cells (Fig. 2d) . However, CD3ζ immunostaining revealed that clustering of the TCR/CD3 complex at the immune synapse was impaired in these cells (Fig. 2e, g ). Moreover, the number of conjugates with TCR/CD3 clustering at the immune synapse was significantly reduced (IFT20-knockdown cells Clustering at the immune synapse is required to bring the TCR close to the tyrosine kinase Lck, which phosphorylates conserved motifs in the intracellular domains of the CD3 complex. These motifs recruit the tyrosine kinase ZAP-70, which becomes activated and phosphorylates key protein substrates to initiate TCR signalling 12 . To assess the outcome of IFT20 knockdown on signalling by the TCR at the immune synapse, SEE-specific conjugates were immunostained with anti-phospho-tyrosine antibodies. Compared with control cells, where strong and localized staining at the immune synapse was observed in a large proportion of conjugates (75%, n = 139), a small proportion of IFT20-knockdown Jurkat cells (38%, n = 161) contained phosphotyrosine staining at the immune synapse. Staining was, moreover, significantly different, appearing to be weaker and dispersed throughout the cell (Fig. 2e, g ). Similar results were obtained from peripheral T-cells transiently knocked down for IFT20 expression ( Fig. 2f, h ; Supplementary Information, Fig. S3e ). As tyrosine kinase activation occurs at the cell surface in response to TCR engagement, the data suggest a rapid dissociation of phosphorylated proteins from the immune synapse. Consistent with this finding, both the extent and duration of tyrosine phosphorylation was reduced in IFT20-knockdown cells, as assessed by immunoblotting analysis of cell lysates ( Supplementary  Information, Fig. S3b ). Moreover, signalling was not productive, as shown by defective upregulation of the surface activation marker CD69 in response to TCR engagement in IFT20-knockdown cells ( Supplementary Information, Fig. S3c ).
Clustering of the TCR/CD3 complex at the immune synapse is achieved through a combination of lateral diffusion, cytoskeleton-driven movement and polarized recycling 5 . The IFT20 association with both Golgi and post-Golgi compartments suggests a potential role of IFT20 in intracellular trafficking of the TCR/CD3 complex. To investigate this, the proportion of cellular CD3 detectable at the cell surface was measured by flow cytometric analysis of intact and permeabilized cells. Although the total levels of CD3 were similar in control and IFT20-knockdown e c cells, less surface CD3 was expressed in IFT20-knockdown cells than in control cells, resulting in a lower ratio of surface CD3 to total CD3 in IFT20-knockdown cells ( Fig. 3a; Supplementary Information, Fig. S4a) . Conversely, no alteration in the ratio of surface to total receptor was observed either for the chemokine receptor CXCR4 (Fig.3a) or for CD69 (data not shown). These data suggest a role of IFT20 in membrane trafficking of the TCR/CD3 complex.
Assembly of the TCR/CD3 complex is initiated in the endoplasmic reticulum and completed in the Golgi, from where it moves to the cell surface via the canonical exocytic route. Once exposed, the TCR/CD3 complex undergoes several rounds through the constitutive recycling pathway, which involves a di-leucine motif in the CD3γ cytosolic tail, before being targeted for degradation 13 . The rates of both de novo synthesis and constitutive endocytosis leading to degradation are very low, indicating that, in resting cells, surface TCR expression is principally dependent on TCR recycling 13, 14 . To investigate the potential role of IFT20 in this process, we capitalized on the capacity of phorbol esters to activate a pathway that depends on PKC (protein kinase C)-mediated activation of the CD3γ di-leucine motif and leads to TCR recycling 13 . Control and IFT20-knockdown cells were treated with PDBu (phorbol 12,13-dibutyrate) for 1 h, which resulted in ~40% TCR internalization. The time course of surface CD3 recovery after PDBu removal was monitored by flow cytometry. In contrast with control cells, which readily recovered surface CD3, no increase in surface CD3 was detected in IFT20-knockdown cells (Fig. 3b) , suggesting that, whereas IFT20 is dispensable for internalization of the TCR/CD3 complex, it is required for TCR/CD3 recycling back to the cell surface. To address this point further, control and IFT20-knockdown cells were incubated for 16 h at 20 °C to block trafficking through constitutively recycling endosomes (which resulted in ~40% reduction of surface CD3) and were then shifted to 37 °C for 4 h. The 37 °C shift resulted in recovery of surface CD3 in control, but not in IFT20-knockdown, cells (Fig. 3c) . No changes in total CD3 were observed after either the 20 °C block or the 37 °C shift ( Supplementary Information, Fig. S4b ). Ligand-dependent TCR endocytosis, while activating an alternative pathway which leads to receptor degradation in lysosomes 13 , was also not affected by IFT20 knockdown, as measured in a time course analysis of TCR internalization ( Supplementary Information, Fig. S4c ), further ruling out endocytosis defects. Collectively, these data support the notion that IFT20 controls TCR/CD3 exocytosis through the constitutive recycling pathway. Recycling endosomes have been demonstrated to polarize to the immune synapse, thereby providing a means of TCR/CD3 enrichment at this location 9 . Notably, as opposed to control cells, recycling endosomes failed to polarize to the immune synapse, both in IFT20-knockdown Jurkat cells ( Fig. 3d; Supplementary Information, Fig. S5 ) and in peripheral T-cells transiently knocked down for IFT20 expression (Fig. 3e) , indicating that IFT20 is required for polarized TCR/CD3 recycling.
In primary cilia IFT20 is a subunit of complex B, one of the two multiprotein complexes forming the IFT particle 1, 2 . To understand whether IFT20 interacts with other IFT components in the absence of primary cilia, T cells were tested by immunoblotting for expression of other complex-B components. Both human and murine cells were found to express IFT88 and IFT57, as well as the kinesin Kif3a, the motor powering anterograde IFT (Fig. 4a) . Co-immunoprecipitation experiments revealed the existence of an IFT20-IFT88-IFT57 complex, which was enhanced in response to TCR engagement (Fig. 4b) . Similarly to IFT20, IFT88 and IFT57 inducibly interacted with the TCR/CD3 complex in response to stimulation (Fig. 4b) . Moreover, immunofluorescence analysis showed that IFT57, which was found to colocalize to a significant extent with IFT20 in resting cells (Fig. 4c) , clustered with the TCR and IFT20 at the immune synapse (Fig. 4d) . Remarkably, both the association of IFT88 with IFT57 and their interaction with the TCR/CD3 complex were impaired in IFT20-knockdown cells (Fig. 4b) . Furthermore, IFT57 was not recruited to the immune synapse in IFT20-knockdown cells (Fig. 4d, e) . Notably, similar to the results obtained from IFT20-knockdown cells, transient knockdown of Kif3a by RNAi resulted in defective antigen-specific conjugate formation (73.4% of control cells, n = 79 versus 50.3% of Kif3a-knockdown cells, n = 145) and impaired T-cell activation, as shown by the reduction in TCR-dependent CD69 expression (Fig. 4f) . Taken together, these data indicate that IFT20 drives the assembly of IFT-like particles in T-lymphocytes in response to TCR engagement, and they support the notion that IFT20 functions together with other IFT components in immune synapse formation and T-cell activation.
T-cell commitment to activation requires sustained TCR signalling 15 . MTOC-driven polarization of recycling endosome-localized TCR/CD3 complexes to the to the immune synapse represents an important means of mobilizing fresh supplies of receptor to this location as engaged receptors are internalized and targeted to lysosomes for degradation 9 . Our data show that IFT20 contributes to the formation of a functional immune synapse by regulating TCR/CD3 recycling (Fig. 5) . The inducible association of IFT20, IFT88 and IFT57 with the TCR/CD3 complex suggests that, in response to a signal triggered by surface TCRs, initially clustered at the immune synapse through lateral diffusion and F-actin-dependent movement 5 , IFT20, in concert with IFT88 and IFT57, may assist in delivering recycling endosome-localized TCR/CD3 to the immune synapse while the MTOC polarizes towards the contact site with the APC.
Based on the structural similarities of IFT components with COPI (coat protein complex I) proteins 16 , which are involved in exocytosis and endosome function 17 , it has been hypothesized that IFT evolved as a specialized form of coated vesicle transport. In this model, coated vesicle transport from the Golgi defined a new plasma membrane domain, which then evolved to become the modern cilium 16 . This idea is supported by the finding that, in ciliated cells, IFT20 is not only localized to cilia and the peri-basal body region, like the other IFT polypeptides, but is also linked to the Golgi through the golgin GMAP210 (refs 3, 18) , suggesting that it may function as an adaptin in coupling to the IFT particle vesicles containing membranous protein cargo destined for the cilium. Our data strengthen this hypothesis by providing the first evidence that in cells lacking cilia, such as T-lymphocytes, an IFT-like particle (whose assembly is driven by IFT20 in response to extracellular cues) is integrated in the membrane trafficking pathways to orchestrate central processes, such as signalling at the immune synapse. In these cells, the membrane patch at the immune synapse, with the underlying MTOC, would represent the functional homologue of the primary cilium. This specialized membrane patch would transiently and inducibly assemble to coordinate the rapid movement of specific membranous cargo -the TCR/CD3 complex -towards the contact site with the APC. A major general implication of these data is that IFT proteins may participate in intracellular membrane trafficking in all eukaryotic cells in addition to their well established roles in ciliary assembly. In this respect, the association of defects in IFT motors and particles with human diseases such as polycystic kidney disease, situs inversus and retinal degeneration 19 , which have been attributed to impaired ciliogenesis, may need to be revised in the wider context of intracellular protein trafficking.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturecellbiology/.
Note: Supplementary Information is available on the Nature Cell Biology website.
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Cells, plasmids, antibodies and reagents. Cell lines included Jurkat T cells and
Raji B cells, both of human origin. Stable IFT20-knockdown Jurkat transfectants were generated as described previously 20 using two pGP676.13 plasmid constructs containing the complementary oligonucleotides corresponding to the coding region of human IFT20 (ref. 3) . Human Kif3a-specific siRNAs (5´-GCCUAAAGGAAGCUACAAA-3´ and 5´-UUUGUA GCUUCCUUUA-GGC-3´, Sigma-Aldrich) were transfected by electroporation and assays carried out after 72 h.
Human peripheral blood mononuclear cells (PBMCs) were purified from whole blood by density gradient centrifugation on Ficoll-Paque (Amersham Pharmacia Italia srl) and subsequently depleted of monocytes by adherence. T and B cells were purified from monocyte-depleted PBMCs, by negative or positive selection, respectively, by immunomagnetic sorting using anti-CD19 antibody-conjugated beads (Dynal Biotech). Cells were then checked for purity (which was consistently > 90%) by flow cytometry with fluorochrome-conjugated anti-CD3/anti-CD19 mAbs. Peripheral T-cells, purified with the StemSep Human T-cell enrichment kit (Voden medical Instruments SpA), were transfected with the same plasmids used for Jurkat cells using the Amaxa nucleofector device (Amaxa Biosystems) and the conditions for T-cell transfection recommended by the manufacturer. Cells were analysed 24 h and 48 h post-transfection. For the TfR labelling experiments, SEB-specific T-cells were expanded before transfection as described previously 9 . Dendritic cells were derived from peripheral blood monocytes from healthy donors as described previously 21 . Mouse cells were derived from 129sv mice (Charles River Italia). Mice were killed by cervical dislocation and thymus, lymph nodes, spleen, bone marrow and testis were collected. Single-cell suspensions were prepared using cell strainer filters (BD Falcon; BD Biosciences Europe). Bone marrow was obtained from femurs by flushing with RPMI supplemented with 7.5% fetal calf serum, and single-cell suspensions were prepared by gentle pipetting. Animal experiments were performed in agreement with the Guiding Principles for Research Involving Animals and Human Beings and approved by the local ethics committees. Polyclonal anti-IFT20, -IFT57 and -IFT88 antibodies were previously described 22 . Anti-TfR mAb (hybridoma OKT9) was provided by A. Alcover (Institut Pasteur, Paris, France). Anti-CXCR4 antibodies were provided by J. Hoxie (University of Pennsylvania, PA, USA), Leukosite and the MRC AIDS Reagent Project. IgG from OKT3 (anti-CD3; American Type Culture Collection) hybridoma supernatants were purified using Mabtrap (Amersham Biosciences Inc.) and titrated by flow cytometry. Anti-Kif3a antibodies were from Sigma-Aldrich; anti-phosphotyrosine and anti-LAT antibodies from Upstate Biotechnology Inc.; anti-CD3ε, anti-CD3ζ mAb from Santa Cruz Biotechnology; anti-LAMP-1 mAb from Developmental Studies Hybridoma Bank; anti-actin mAb from Chemicon International Inc.; anti-GM130 and anti-EEA1 mAb from BD Biosciences; anti-γ-tubulin from Sigma; anti-β-tubulin from Boehringer; anti-TGN46 from AbD Serotec. Unlabelled secondary antibodies were from Cappel (ICN Pharmaceuticals Inc), and secondary peroxidase-labelled antibodies from Amersham Pharmacia Biotech. Alexa Fluor 488-and 555-labelled secondary antibodies were from Molecular Probes (Invitrogen srl), FITC-conjugated antimouse Ig from DAKO (Glostrup). FITC or PE-labelled anti-human CD69, CD3 and CD19 were purchased from BD Biosciences.
Staphylococcal enterotoxin B (SEB) and E (SEE) was purchased from Toxin Technology, Cell Tracker Blue from Molecular Probes, poly-L-lysine, phorbol 12,13-dibutyrate (PDBu) and Brefeldin-A from Sigma.
Golgi extraction. For the Golgi extraction, Jurkat cells were plated on polylysinecoated wells of diagnostic microscope slides (Erie Scientific Company), where they were allowed to adhere for 15 min. After adhesion, cells were pre-extracted with PBS containing 0.1% Triton X-100 for 30 s and fixed for 10 min in methanol at -20 °C. Alternatively, cells were treated with 10 μg ml -1 Brefeldin A for 30 min at 37 °C and, after washing, frozen on microscope slides and fixed in cold methanol.
Activations, immunoprecipitations and immunoblotting.
Activation by TCR/ CD3 cross-linking was performed by incubating Jurkat cells with saturating concentrations of anti-CD3 mAb and 50 μg ml -1 secondary antibodies for 1-10 min at 37 °C as described previously 23 . Cells (1×10 6 per sample for direct immunoblotting analysis, 5×10 7 per sample for immunoprecipitations) were lysed in 1% Triton X-100 in 20 mM Tris-HCl (pH 8) and 150 mM NaCl in the presence of a protease inhibitor cocktail, and postnuclear supernatants were probed as such or immunoprecipitated using anti-IFT20, -IFT88 or -IFT57 polyclonal antibodies and protein A-Sepharose (Amersham). Immunoblotting was carried out using primary antibodies and peroxidase-labelled secondary antibodies, according to the manufacturer's instructions and a chemiluminescence detection kit (Pierce Rockford.). All blots were reprobed with loading (anti-actin mAb) or immunoprecipitation (anti-IFT20, -IFT57, -IFT88) control antibodies after stripping. Blots were scanned using a laser densitometer (Duoscan T2500; Agfa) and quantified using the ImageQuant 5.0 software (Molecular Dynamics).
For analysis of CD69 expression, cells (1×10 6 cells per sample) were activated by CD3 cross-linking on secondary antibody-coated plates as described previously 23 and were processed for flow cytometry 8 h after activation.
Flow cytometry. CD3, CD69 or CXCR4 expression on Jurkat transfectants and purified peripheral T-cells was quantified by flow cytometry using fluorochrome-labelled mAb (CD3, CD69) or unlabelled antibody (CXCR4) followed by FITC-labelled secondary antibodies. To analyse total expression of CD3, CD69 and CXCR4, cells were fixed in 4% paraformaldehyde in PBS for 20 min, incubated in PBS 1% BSA for 20 min, permeabilized with PBS 0.1% Triton X-100 and labelled as above. CD3 recycling was induced by treatment with PDBu. Control and IFT20-knockdown Jurkat cells (1×10 6 cells ml -1 RPMI1640 supplemented with 10% serum) were stimulated with 1 μM PDBu for 1 h at 37 °C, washed at 4 °C and transferred to 37 °C for 1-60 min. Surface CD3 expression was measured at all time points by flow cytometry.
To block endosome recycling, control and IFT20-knockdown Jurkat cells were incubated at 20 °C for 16 h (1×10 6 cells ml -1 RPMI1640 supplemented with 10% serum). Cells were subsequently washed and transferred to 37 °C for 4 h. Surface and total CD3 expression was measured by flow cytometry as described above. TCR internalization was quantified as described previously 24, 25 . Flow cytometry was carried out using a FACScan flow cytometer (Becton Dickinson). Data were acquired using CellQuest and analysed and plotted using Flowjo (TreeStar). Alternatively, peripheral T-cells purified from healthy donors and transiently transfected with either empty vector or the IFT20 RNAi construct were mixed with SEE/SEB-pulsed APCs and processed as above. Cells were allowed to adhere for 15 min and then fixed in methanol at -20 °C for 10 min, as described above. Antigen-independent conjugates were obtained by mixing T-cells and APCs in the absence of SEE/SEB. To induce capping, Jurkat cells were incubated for 30 min with anti-CD3ε mAb at 4 °C and, after washing, incubated at 37 °C with secondary Alexa Fluor 488-conjugated secondary antibodies for 10 min. Cells were then washed, flash-frozen and fixed as described above.
Following fixation, samples were washed for 5 min in PBS and incubated with primary antibodies overnight at 4 °C or 1 h at room temperature. After washing in PBS, samples were incubated for 1 h at room temperature with Alexa Fluor 488-and 555-labelled secondary antibodies. For the triple staining experiment, the anti-IFT20 antibody was labelled with a Zenon Rabbit IgG Labeling Kit (Molecular Probes), using Alexa Fluor-546 as fluorochrome, and IFT57 and CD3ζ were stained with Alexa Fluor-488 and -647 labelled secondary antibodies, respectively. To better visualize surface CD3 and surface TfR, which are partially lost in methanol-fixed cells, in one experiment SEE-specific conjugates were also fixed in 4% paraformaldehyde and stained with anti-CD3ε or anti-TfR mAb ( Supplementary Information, Figs S3a and S5a, b) .
Confocal microscopy was carried out on a Zeiss LSM510 using a 63X objective. Z series of optical sections were performed at 0.5-μm increments. Images to quantify were acquired with pinholes opened to obtain optical sections of 0.6-μm. Detectors were set to detect an optimal signal below the saturation limits. Image sets to be compared were acquired during the same session and using the same acquisition settings. Images were processed with LSM5 Image Examiner software (Carl Zeiss).
Epifluorescence microscopy was carried out using an Axio Imager Z1 (Carl Zeiss) microscope equipped with a HBO 50-W mercury lamp for epifluorescence and with an AxioCam HR cooled charge-coupled camera (Carl Zeiss). Grey-scale digital images were collected separately and then pseudo-coloured and merged using Adobe Photoshop 7.0 software (Adobe Systems). If required, images were adjusted for contrast in Adobe Photoshop. When comparisons were to be made between images, the photos were taken in identical conditions and manipulated equally.
Post-processing of confocal images, colocalization analyses and 3D reconstructions. Clustering or relocalization of molecules and organelles at the T cell-APC contact site was quantified on median optical confocal sections using ImageJ software (downloaded from http://www.embl-heidelberg.de/eamnet/) and expressed either as relative recruitment index (IFT20, CD3ζ, PTyr, TfR) or as distance of the centre of the organelle from the T cell-APC contact site (MTOC, Golgi), as described previously 9, 26 . Post-processing of the confocal images included an initial segmentation by a semi-automatic intensity-independent zero-crossing procedure, which allowed the identification of the boundaries of the organelles/compartments 27 . Specifically, colocalization analysis and 3D reconstructions were performed on the images segmented by an edge-detection intensity-independent zero-crossing procedure. In this procedure, the edges of the structural elements are assumed to correspond to the inflection points of the intensity functions. At these positions, the absolute values of the slope are maximal, and therefore the first derivative shows a maximum, and the Laplacian (the second derivative) changes sign, that is, crosses zero 28 . These zero-crossings have thus been used as the tool for the recognition of edges/surfaces in 2D/3D microscopy imaging 27 . Briefly, all of the images were slightly pre-smoothed with a Gaussian filter (σ = 2) to reduce noise and the background pixels below 15% of the maximum point spread function intensity were cut before calculating the zero-crossing algorithm, which was run through a dedicated MATLAB (The Mathworks Inc., R2006b) routine. The same MATLAB routine was used to calculate the weighted colocalizations (see below). Finally, the DIPimage software (version 1.6, http://www.diplib.org/), was used to develop the 3D reconstructions readable in the Visual Molecular Dynamics package (version 1.8.5, http://www.ks.uiuc.edu/Research/vmd/), which was used to visualize these 3D reconstructions.
Object-based weighted colocalizations of each of the examined organelles/compartments with the IFT20 staining, and the corresponding 3D reconstructions, were elaborated from the segmented images as described previously 27 . First, after the zero-crossing segmentation has been performed, only the remaining pixels for each channel are taken into account. Second, these pixels are subdivided into three regions: all the pixels where only channel 1 (IFT20) is present belong to region 1, all the pixels where only channel 2 (any other marker) is present belong to region 2. Finally, all pixels where both channels are present belong to region 3. For the weighted colocalization of any of the cellular compartment/organelle (region 2) with IFT20 (region 1), the ratio between the intensity of pixels in region 3 to the intensities of pixels in region 2+3 was calculated. The measurements, which highlight the TfR polarization specifically on the T-cell side of the T-cell:APC contact site in antigen-specific conjugates of control Jurkat cells (but not IFT20-KD cells), were taken on conjugates from at least 3 independent experiments (n=50 conjugates). Error bars, SD.
